dr. jason luke talks about advances in how melanoma is diagnosed
Published 8 years ago • 262 plays • Length 1:09Download video MP4
Download video MP3
Similar videos
-
1:30
dr. jason luke on sequencing targeted and immunotherapy agents in braf melanoma
-
1:20
dr. luke on immunotherapy advancements in melanoma
-
1:51
dr. luke on immunotherapy diagnostics in melanoma
-
1:41
dr. luke discusses combination approaches on horizon in melanoma
-
5:32
melanoma matters: melanoma and life expectancy (julie's story)
-
23:12
it's melanoma, now what?
-
20:55
what is stage iv melanoma?
-
2:05
dr. luke on challenges with immunotherapy in melanoma
-
1:10
dr. luke on ongoing studies with immunotherapy in melanoma
-
1:30
dr. jason luke discusses nivolumab and pembrolizumab in melanoma
-
1:25
dr. jason luke on potential for ido inhibitors in melanoma
-
1:06
jason luke, md: the impact of braf/mek inhibitors in melanoma
-
0:56
jason j. luke, md, facp, on the most compelling data in metastatic melanoma from esmo 2019
-
0:52
dr. luke discusses the combination of epacadostat and pembrolizumab in melanoma
-
1:06
dr. luke on the future role of immunotherapy combinations in melanoma
-
1:31
jason j. luke, md, facp, on how data from esmo 2019 may impact the treatment of melanoma
-
7:30
immunotherapy in advanced melanoma
-
1:48
dr. luke on current and emerging treatment approaches in metastatic melanoma
-
1:10
dr. luke on the nurse’s role in managing melanoma toxicities
-
1:01
dr. luke on the future of combination therapy in melanoma
-
4:15
stage iv melanoma cancer treatment options explained: immunotherapy and targeted therapy
-
10:21
melanoma diagnosis, now what?